CellSource Co

CellSource Co Cash Flow per Share

The Operating Cash Flow per Share of CellSource Co (4880.T) as of Oct 29, 2026 is 16.81 JPY. In the previous year, Operating Cash Flow per Share was 29.88 JPY — a change of -43.75% (lower).

Cash Flow per Share

16.81JPY

YoY

-43.75%

Last updated:

Operating Cash Flow per Share of CellSource Co is 2025 16.81 JPY. Operating Cash Flow per Share of CellSource Co was 2024 29.88 JPY. It decreases by -43.75% lower compared to the previous year.

The CellSource Co Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
10.75 JPY
Jan 1, 2019
11.30 JPY
Jan 1, 2020
17.23 JPY
Jan 1, 2021
46.74 JPY
Jan 1, 2022
44.11 JPY
Jan 1, 2023
43.65 JPY
Jan 1, 2024
29.88 JPY
Jan 1, 2025
16.81 JPY
The CellSource Co Cash Flow per Share history
YEARCash Flow per ShareYoY
16.81JPY-43.75%
29.88JPY-31.55%
43.65JPY-1.06%
44.11JPY-5.63%
46.74JPY+171.32%
17.23JPY+52.44%
11.30JPY+5.09%
10.75JPY+94.62%
5.53JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Operating Cash Flow per Share of CellSource Co is 16.81 JPY in 2025.

Operating Cash Flow per Share of CellSource Co changed from 29.88 JPY to 16.81 JPY, representing a -43.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — CellSource Co

All Key Metrics — CellSource Co